Opaleye Management’s Loxo Oncology, Inc LOXO Stock Holding History

Opaleye Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-175,000	Closed	-$24.5M	–	66
2018 Q4	$24.5M	Hold	175,000	–	–	9.15%	3
2018 Q3	$29.9M	Hold	175,000	–	–	7.61%	3
2018 Q2	$30.4M	Sell	175,000 -4,400	-2%	-$661K	7.86%	2
2018 Q1	$20.7M	Buy	179,400 +3,100	+2%	+$330K	5.92%	3
2017 Q4	$14.8M	Buy	176,300 +46,300	+36%	+$3.86M	4.75%	4
2017 Q3	$12M	Hold	130,000	–	–	4.23%	5
2017 Q2	$10.4M	Hold	130,000	–	–	4.35%	4
2017 Q1	$5.47M	Buy	130,000 +5,000	+4%	+$206K	2.72%	14
2016 Q4	$4.01M	Buy	125,000 +15,000	+14%	+$384K	2.37%	16
2016 Q3	$2.88M	Buy	+110,000	New	+$2.88M	1.51%	25

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Opaleye Management's LOXO Position: Q1 2019 in Review

Opaleye Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 175,000 shares — an estimated $24.5M sold.

Opaleye Management first reported a position in LOXO in Q3 2016 and held it in 10 quarters. The position peaked at $30.4M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Opaleye Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Opaleye Management sold 175,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $24.5M.
Opaleye Management first reported a position in Loxo Oncology, Inc in Q3 2016 and held it in 10 quarters.
Opaleye Management's Loxo Oncology, Inc position peaked at $30.4M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Opaleye Management's 13F filing for Q1 2019, filed 15 May 2019.